We are a COVID-19 Testing Facility

Are you or a loved one interested in participating in a Non-Small Cell Lung Cancer clinical trial?

This is a clinical trial for adults who have been diagnosed with MET-overexpressed and/or amplified, locally advanced or metastatic NSCLC who have progressed on first- or second-line treatment with osimertinib as the most recent therapy.

Why is the SAFFRON study being done?

The purpose of this study is to determine the direct effect of savolitinib in combination with osimertinib in comparison to platinum-based doublet chemotherapy as it is not confounded by the efficacy of subsequent therapies used after disease progression.

Who can participate in the SAFFRON study?

You may be eligible to participate in this study if you:

What happens during the study?

There are 3 study periods: screening, treatment, and follow-up. All aspects of your participation will take place at the study location or at your place of residence.

Screening:

Intervention:

Post-Intervention:

What treatment will I receive?

You will receive both daily by mouth.
What tests will I have?

What else will I have to do?

Will I receive compensation for participating in this study?

GenHarp Clinical Solutions

9730 S. Western Ave., Suite 218 Evergreen Park, IL 60805
872-205-3149